{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:57:33Z","timestamp":1791280653894,"version":"4.1.0"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ejphar.2015.06.027","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T04:17:04Z","timestamp":1434687424000},"page":"15-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"special_numbering":"PA","title":["Drug induced hypertension \u2013 An unappreciated cause of secondary hypertension"],"prefix":"10.1016","volume":"763","author":[{"given":"Alon","family":"Grossman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz H.","family":"Messerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehud","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2015.06.027_bib1","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.2217\/fon.14.42","article-title":"Risk of cardiovascular toxicities in patients with solid tumors treated with sorafenib: an updated systematic review and meta-analysis","volume":"10","author":"Abdel-Rahman","year":"2014","journal-title":"Future Oncol."},{"key":"10.1016\/j.ejphar.2015.06.027_bib2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.critrevonc.2014.06.003","article-title":"Risk of cardiovascular toxicities in patients with solid tumors treated with sunitinib, axitinib, cediranib or regorafenib: an updated systematic review and comparative meta-analysis","volume":"92","author":"Abdel-Rahman","year":"2014","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.ejphar.2015.06.027_bib3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-5122(01)00196-7","article-title":"Effects of hormonal replacement therapy in postmenopausal hypertensive patients","volume":"40","author":"Affinito","year":"2001","journal-title":"Maturitas"},{"key":"10.1016\/j.ejphar.2015.06.027_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0149-2918(03)90003-8","article-title":"The impact of nonsteroidal anti-inflammatory drugs on blood pressure, with an emphasis on newer agents","volume":"25","author":"Armstrong","year":"2003","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejphar.2015.06.027_bib5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archinte.165.5.ioi50013","article-title":"Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure","volume":"165","author":"Aw","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ejphar.2015.06.027_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00005082-200207000-00007","article-title":"Herbal interactions with cardiovascular drugs","volume":"16","author":"Awang","year":"2002","journal-title":"J. Cardiovasc. Nurs."},{"key":"10.1016\/j.ejphar.2015.06.027_bib7","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1097\/HJH.0b013e32830ef5fb","article-title":"Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy","volume":"26","author":"Baekken","year":"2008","journal-title":"J. Hypertens."},{"issue":"528","key":"10.1016\/j.ejphar.2015.06.027_bib8","article-title":"\u201cOne\u201d cup of coffee and nuclear SPECT to go","volume":"49","author":"Bangalore","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2015.06.027_bib9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1527-3458.2006.00250.x","article-title":"Paracetamol: new vistas of an old drug","volume":"12","author":"Bertolini","year":"2006","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.ejphar.2015.06.027_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/08037051.2013.832967","article-title":"Apparent mineralcorticoid excess syndrome, an often forgotten or unrecognized cause of hypokalemia and hypertension: case report and appraisal of the pathophysiology","volume":"23","author":"Bisogni","year":"2014","journal-title":"Blood Press"},{"key":"10.1016\/j.ejphar.2015.06.027_bib11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/annonc\/mdn729","article-title":"Hypertension and clinical benefit of bevacizumab in the treatment of advanced renal cell carcinoma","volume":"20","author":"Bono","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejphar.2015.06.027_bib12","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.contraception.2013.04.003","article-title":"Modification of 24-h ambulatory blood pressure and heart rate during contraception with the vaginal ring: a prospective study","volume":"88","author":"Cagnacci","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.ejphar.2015.06.027_bib13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1086\/313728","article-title":"Severe hypertension and renal atrophy associated with indinavir","volume":"30","author":"Cattelan","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejphar.2015.06.027_bib14","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1097\/HJH.0b013e3283310dc9","article-title":"Do COX-2 inhibitors raise blood pressure more than nonselective NSAIDs and placebo? An updated meta-analysis","volume":"27","author":"Chan","year":"2009","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2015.06.027_bib15","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.94.3.483","article-title":"Prospective study of oral contraceptives and hypertension among women in the United States","volume":"94","author":"Chasan-Taber","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2015.06.027_bib16","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1097\/00004872-200112000-00025","article-title":"Cyclosporin-induced hypertension","volume":"19","author":"Cifkova","year":"2001","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2015.06.027_bib17","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/j.1524-6175.2006.05177.x","article-title":"Does consumption of high-caffeine energy drinks affect blood pressure?","volume":"8","author":"Cohen","year":"2006","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.ejphar.2015.06.027_bib18","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/01.aids.0000222074.45372.00","article-title":"Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy","volume":"20","author":"Crane","year":"2006","journal-title":"Aids"},{"key":"10.1016\/j.ejphar.2015.06.027_bib19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2165\/00002512-199711030-00003","article-title":"Drug-induced hypertension. Recognition and management in older patients","volume":"11","author":"de Leeuw","year":"1997","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ejphar.2015.06.027_bib20","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/annonc\/mdm205","article-title":"Treatment of arterial hypertension (AHT) associated with angiogenesis inhibitors","volume":"18","author":"Dirix LYMaes","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejphar.2015.06.027_bib21","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1524-6175.2006.05939.x","article-title":"Drug interactions and drugs that affect blood pressure","volume":"8","author":"Elliott","year":"2006","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.ejphar.2015.06.027_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa060655","article-title":"Sorafenib in advanced clear-cell renal-cell carcinoma","volume":"356","author":"Escudier","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2015.06.027_bib23","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2165\/00003088-200241140-00004","article-title":"Interactions between antiretroviral drugs and drugs used for the therapy of the metabolic complications encountered during HIV infection","volume":"41","author":"Fichtenbaum","year":"2002","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2015.06.027_bib24","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/archinte.167.4.394","article-title":"Frequency of analgesic use and risk of hypertension among men","volume":"167","author":"Forman","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ejphar.2015.06.027_bib25","doi-asserted-by":"crossref","first-page":"f6954","DOI":"10.1136\/bmj.f6954","article-title":"Association between cardiovascular events and sodium-containing effervescent, dispersible, and soluble drugs: nested case-control study","volume":"347","author":"George","year":"2013","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ejphar.2015.06.027_bib26","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1468-1293.2006.00400.x","article-title":"Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study","volume":"7","author":"Glass","year":"2006","journal-title":"HIV Med."},{"key":"10.1016\/j.ejphar.2015.06.027_bib27","doi-asserted-by":"crossref","first-page":"H1395","DOI":"10.1152\/ajpheart.01277.2005","article-title":"Mechanisms of endothelial response to oxidative aggression: protective role of autologous VEGF and induction of VEGFR2 by H2O2","volume":"291","author":"Gonzalez-Pacheco","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ejphar.2015.06.027_bib28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1310\/hct0901-52","article-title":"Short-term effect of HAART on blood pressure in HIV-infected individuals","volume":"9","author":"Grandominico","year":"2008","journal-title":"HIV Clin. Trials"},{"key":"10.1016\/j.ejphar.2015.06.027_bib29","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/archinte.1995.00430050022003","article-title":"High blood pressure. A side effect of drugs, poisons, and food","volume":"155","author":"Grossman","year":"1995","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ejphar.2015.06.027_bib30","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1751-7176.2008.07758.x","article-title":"Secondary hypertension: interfering substances","volume":"10","author":"Grossman","year":"2008","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.ejphar.2015.06.027_bib31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2011.05.024","article-title":"Drug-induced hypertension: an unappreciated cause of secondary hypertension","volume":"125","author":"Grossman","year":"2012","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2015.06.027_bib32","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1517\/14656566.2013.816286","article-title":"Effect of naproxen and acetaminophen on blood pressure lowering by ramipril, valsartan and aliskiren in hypertensive patients","volume":"14","author":"Gualtierotti","year":"2013","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ejphar.2015.06.027_bib33","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11906-014-0468-2","article-title":"Blood pressure in relation to coffee and caffeine consumption","volume":"16","author":"Guessous","year":"2014","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.ejphar.2015.06.027_bib34","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1056\/NEJM200012213432502","article-title":"Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids","volume":"343","author":"Haller","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2015.06.027_bib35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/cncr.28972","article-title":"Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway","volume":"121","author":"Hamnvik","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.ejphar.2015.06.027_bib36","first-page":"58","article-title":"Hypertension among HIV-infected adults receiving highly active antiretroviral therapy (HAART) in Malaysia, Glob","volume":"6","author":"Hejazi","year":"2014","journal-title":"J. Health Sci."},{"key":"10.1016\/j.ejphar.2015.06.027_bib37","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1096\/fj.07-8506com","article-title":"Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man","volume":"22","author":"Hinz","year":"2008","journal-title":"Faseb J."},{"key":"10.1016\/j.ejphar.2015.06.027_bib38","first-page":"H1054","article-title":"VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells","volume":"274","author":"Hood","year":"1998","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2015.06.027_bib39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5301\/jn.5000174","article-title":"Pathogenesis of calcineurin inhibitor-induced hypertension","volume":"25","author":"Hoorn","year":"2012","journal-title":"J. Nephrol."},{"key":"10.1016\/j.ejphar.2015.06.027_bib40","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2015.06.027_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.contraception.2003.09.002","article-title":"Progestogen-only pills and high blood pressure: is there an association? A literature review","volume":"69","author":"Hussain","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.ejphar.2015.06.027_bib42","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/annonc\/mdn713","article-title":"Management of hypertension in angiogenesis inhibitor-treated patients","volume":"20","author":"Izzedine","year":"2009","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejphar.2015.06.027_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2003.06.039","article-title":"Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction","volume":"98","author":"Izzo","year":"2005","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ejphar.2015.06.027_bib44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00002018-199717050-00001","article-title":"NSAIDs and increased blood pressure. What is the clinical significance?","volume":"17","author":"Johnson","year":"1997","journal-title":"Drug Saf."},{"key":"10.1016\/j.ejphar.2015.06.027_bib45","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.amjhyper.2005.01.020","article-title":"Isradipine decreases the hemodynamic response of cocaine and methamphetamine results from two human laboratory studies: results from two human laboratory studies","volume":"18","author":"Johnson","year":"2005","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2015.06.027_bib46","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1161\/HYPERTENSIONAHA.109.149690","article-title":"Hypertension induced by the tyrosine kinase inhibitor sunitinib is associated with increased circulating endothelin-1 levels","volume":"56","author":"Kappers","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2015.06.027_bib47","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0002-9343(98)00370-2","article-title":"Hypertensive crisis secondary to phenylpropanolamine interacting with triple-drug therapy for HIV prophylaxis","volume":"106","author":"Khurana","year":"1999","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2015.06.027_bib48","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1056\/NEJM197705262962103","article-title":"Alcohol consumption and blood pressure Kaiser\u2013Permanente Multiphasic Health Examination data","volume":"296","author":"Klatsky","year":"1977","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2015.06.027_bib49","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1634\/theoncologist.2009-0071","article-title":"Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study","volume":"14","author":"Kozloff","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.ejphar.2015.06.027_bib50","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/2325957413491432","article-title":"Correlates of hypertension in patients with AIDS in the era of highly active antiretroviral therapy","volume":"12","author":"Krauskopf","year":"2013","journal-title":"J. Int. Assoc. Provid. AIDS Care"},{"key":"10.1016\/j.ejphar.2015.06.027_bib51","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/HJH.0b013e328325d831","article-title":"Factors associated with blood pressure changes in patients receiving diclofenac or etoricoxib: results from the MEDAL study","volume":"27","author":"Krum","year":"2009","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2015.06.027_bib52","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/HYPERTENSIONAHA.114.04187","article-title":"Treatment of hypertension and renal injury induced by the angiogenesis inhibitor sunitinib: preclinical study","volume":"64","author":"Lankhorst","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2015.06.027_bib53","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/IAE.0b013e3181b21056","article-title":"A prospective study of blood pressure and intraocular pressure changes in hypertensive and nonhypertensive patients after intravitreal bevacizumab injection","volume":"29","author":"Lee","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.ejphar.2015.06.027_bib54","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/pbc.21866","article-title":"Reversible posterior leukoencephalopathy syndrome in a child treated with bevacizumab","volume":"52","author":"Levy","year":"2009","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ejphar.2015.06.027_bib55","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2015.06.027_bib56","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2141.1985.tb07342.x","article-title":"Incidence of hypertension after marrow transplantation among 112 patients randomized to either cyclosporine or methotrexate as graft- versus-host disease prophylaxis","volume":"59","author":"Loughran","year":"1985","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejphar.2015.06.027_bib57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00004872-198402000-00015","article-title":"Obesity, alcohol consumption and blood pressure in Australian men and women. The National Heart Foundation of Australia Risk Factor Prevalence Study","volume":"2","author":"MacMahon","year":"1984","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2015.06.027_bib58","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1158\/1078-0432.CCR-09-0058","article-title":"Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment","volume":"15","author":"Maitland","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2015.06.027_bib59","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.transproceed.2005.06.073","article-title":"Use of mycophenolate mofetil in liver transplantation: a literature review","volume":"37","author":"Manzia","year":"2005","journal-title":"Transplant Proc."},{"key":"10.1016\/j.ejphar.2015.06.027_bib60","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.jacc.2005.06.050","article-title":"Aspirin: a novel antihypertensive drug? Or two birds with one stone?","volume":"46","author":"Messerli","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2015.06.027_bib61","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/ijc.28334","article-title":"Arterial hypertension and cancer","volume":"134","author":"Milan","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejphar.2015.06.027_bib62","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/bmj.39526.654016.AD","article-title":"Does paracetamol cause hypertension?","volume":"336","author":"Montgomery","year":"2008","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ejphar.2015.06.027_bib63","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ndt\/16.suppl_1.121","article-title":"Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation","volume":"16","author":"Morales","year":"2001","journal-title":"Nephrol. Dial Transplant"},{"key":"10.1016\/j.ejphar.2015.06.027_bib64","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1524-6175.2003.00514.x","article-title":"The effect of nonsteroidal anti-inflammatory drugs on blood pressure in patients treated with different antihypertensive drugs","volume":"5","author":"Morgan","year":"2003","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.ejphar.2015.06.027_bib65","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/01.hjh.0000166828.94699.1d","article-title":"Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials","volume":"23","author":"Noordzij","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2015.06.027_bib66","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1592\/phco.23.2.265.32077","article-title":"Erythropoietin-induced hypertensive urgency in a patient with chronic renal insufficiency: case report and review of the literature","volume":"23","author":"Novak","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejphar.2015.06.027_bib67","first-page":"e372","article-title":"Interaction between antihypertensives and NSAIDs in primary care: a controlled trial","volume":"15","author":"Pavlicevic","year":"2008","journal-title":"Can. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.06.027_bib68","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3109\/08923979309035241","article-title":"Cyclosporine in idiopathic nephrotic syndrome","volume":"15","author":"Ponticelli","year":"1993","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.ejphar.2015.06.027_bib69","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3945\/ajcn.111.018267","article-title":"Genetic determinants of blood pressure responses to caffeine drinking","volume":"95","author":"Renda","year":"2012","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ejphar.2015.06.027_bib70","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/00005344-200000001-00002","article-title":"Calcium antagonists and renal protection from cyclosporine nephrotoxicity: long-term trial in renal transplantation patients","volume":"35","author":"Rodicio","year":"2000","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.06.027_bib71","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1097\/HJH.0b013e32834c465d","article-title":"Drug-related hypertension and resistance to antihypertensive treatment: a call for action","volume":"29","author":"Rossi","year":"2011","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2015.06.027_bib72","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.amjhyper.2004.08.011","article-title":"Association of ambulatory blood pressure and dietary caffeine in adolescents","volume":"18","author":"Savoca","year":"2005","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2015.06.027_bib73","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/IAE.0b013e3181b32d13","article-title":"Vascular events in patients with age-related macular degeneration treated with intraocular bevacizumab","volume":"29","author":"Sheybani","year":"2009","journal-title":"Retina"},{"key":"10.1016\/j.ejphar.2015.06.027_bib74","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/j.clinthera.2006.11.015","article-title":"Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies","volume":"28","author":"Shih","year":"2006","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejphar.2015.06.027_bib75","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1081\/JDI-120022548","article-title":"Increased endothelin: nitric oxide ratio is associated with erythropoietin-induced hypertension in hemodialysis patients","volume":"25","author":"Shimada","year":"2003","journal-title":"Ren. Fail."},{"key":"10.1016\/j.ejphar.2015.06.027_bib76","first-page":"505","article-title":"Adverse effects of corticosteroids on the cardiovascular system","volume":"16","author":"Sholter","year":"2000","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ejphar.2015.06.027_bib77","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1517\/17425255.2014.856881","article-title":"Assessment of nonsteroidal anti-inflammatory drug-induced cardiotoxicity","volume":"10","author":"Singh","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejphar.2015.06.027_bib78","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.cjca.2014.02.011","article-title":"Hypertension due to antiangiogenic cancer therapy with vascular endothelial growth factor inhibitors: understanding and managing a new syndrome","volume":"30","author":"Small","year":"2014","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ejphar.2015.06.027_bib79","doi-asserted-by":"crossref","first-page":"83S","DOI":"10.1016\/j.transproceed.2004.01.089","article-title":"Single-center experience with cyclosporine therapy for kidney transplantation: analysis of a twenty-year period in 1200 patients","volume":"36","author":"Snanoudj","year":"2004","journal-title":"Transplant Proc."},{"key":"10.1016\/j.ejphar.2015.06.027_bib80","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/07357909609012161","article-title":"Hypertensive reactions associated with paclitaxel","volume":"14","author":"Solimando","year":"1996","journal-title":"Cancer Invest."},{"key":"10.1016\/j.ejphar.2015.06.027_bib81","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/CIRCULATIONAHA.106.636746","article-title":"Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas","volume":"114","author":"Solomon","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2015.06.027_bib82","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archinte.165.2.161","article-title":"The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus","volume":"165","author":"Sowers","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ejphar.2015.06.027_bib83","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/CIRCULATIONAHA.110.956490","article-title":"Acetaminophen increases blood pressure in patients with coronary artery disease","volume":"122","author":"Sudano","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2015.06.027_bib84","doi-asserted-by":"crossref","first-page":"e84848","DOI":"10.1371\/journal.pone.0084848","article-title":"Effect of erythropoiesis-stimulating agents on blood pressure in pre-dialysis patients","volume":"8","author":"Suttorp","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2015.06.027_bib85","doi-asserted-by":"crossref","first-page":"502","DOI":"10.4088\/JCP.v59n1002","article-title":"Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients","volume":"59","author":"Thase","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ejphar.2015.06.027_bib86","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1161\/HYPERTENSIONAHA.111.00841","article-title":"Role of endogenous vascular endothelial growth factor in endothelium-dependent vasodilation in humans","volume":"61","author":"Thijs","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2015.06.027_bib87","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/bcp.12032","article-title":"A systematic review of the effect of paracetamol on blood pressure in hypertensive and non-hypertensive subjects","volume":"75","author":"Turtle","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2015.06.027_bib88","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1345\/aph.1H659","article-title":"New diagnosis of hypertension among celecoxib and nonselective NSAID users: a population-based cohort study","volume":"41","author":"Wang","year":"2007","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejphar.2015.06.027_bib89","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1016\/j.amjmed.2009.03.004","article-title":"Treatment of patients with hypertension and arthritis pain: new concepts","volume":"122","author":"Weber","year":"2009","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2015.06.027_bib90","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/01.HYP.0000258106.74139.25","article-title":"Cardiovascular effects of the cyclooxygenase inhibitors","volume":"49","author":"White","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2015.06.027_bib91","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S1470-2045(08)70003-2","article-title":"Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis","volume":"9","author":"Wu","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejphar.2015.06.027_bib92","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1097\/01.hjh.0000173394.39197.4e","article-title":"Relationship of alcohol consumption to 7-year blood pressure change in Japanese men","volume":"23","author":"Yoshita","year":"2005","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ejphar.2015.06.027_bib93","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/02841860802314720","article-title":"Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: systematic review and meta-analysis","volume":"48","author":"Zhu","year":"2009","journal-title":"Acta Oncol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915300893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299915300893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T13:21:48Z","timestamp":1537536108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299915300893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":93,"alternative-id":["S0014299915300893"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.06.027","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug induced hypertension \u2013 An unappreciated cause of secondary hypertension","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2015.06.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}